Inhibitors | Comment | Organism | Structure |
---|---|---|---|
adenosine dialdehyde | blocks the action of PRMT7 in ccRCC cells | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
S-adenosyl-L-methionine + [beta-catenin]-L-arginine | Homo sapiens | the enzyme (PRMT7) upregulates the expression of C-MYC via methylating beta-catenin and inhibiting the ubiquitin-mediated degradation of beta-catenin | S-adenosyl-L-homocysteine + [beta-catenin]-Nomega-methyl-L-arginine | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q9NVM4 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
renal cell carcinoma cell | overexpression in renal cell carcinoma | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
S-adenosyl-L-methionine + [beta-catenin]-L-arginine | - |
Homo sapiens | S-adenosyl-L-homocysteine + [beta-catenin]-Nomega-methyl-L-arginine | - |
? | |
S-adenosyl-L-methionine + [beta-catenin]-L-arginine | the enzyme (PRMT7) upregulates the expression of C-MYC via methylating beta-catenin and inhibiting the ubiquitin-mediated degradation of beta-catenin | Homo sapiens | S-adenosyl-L-homocysteine + [beta-catenin]-Nomega-methyl-L-arginine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
PRMT7 | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
drug target | overexpressed PRMT7 in clear cell renal cell carcinoma (ccRCC) cells acts as an oncogene to promote the growth of renal cell carcinoma through regulating the beta-catenin/C-MYC axis, thereby providing new strategies and targets for the treatment of ccRCC patients | Homo sapiens |
physiological function | the enzyme (PRMT7) regulates the expression of C-MYC, which plays an important role in promoting ccRCC cell proliferation, and it accelerates the tumor development of RCC in a C-MYC-dependent manner. It upregulates the expression of C-MYC via methylating beta-catenin and inhibiting the ubiquitin-mediated degradation of beta-catenin | Homo sapiens |